Bilirubin effect on endothelial adhesion molecules expression is mediated by the NF-κB signaling pathway

BioScience Trends

Volumn 3, Issue 4, 2009, Pages 151-157

  Mazzone, Graciela Luján ^a,b   Rigato, Igino ^a,c   Ostrow, J Donald ^d   Tiribelli, Claudio ^a,b  

^a Centro Studi Fegato   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c Hospital of San Vito Al Tagliamento   (Italy)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adhesion molecules; Atherosclerosis; Bilirubin; Endothelial cell activation; Nf b; Tnf

Indexed keywords

BILIRUBIN; CELL ADHESION MOLECULE; CREBBP PROTEIN, MOUSE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROLINE; PROLINEDITHIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE TRANSPORT; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; ATHEROSCLEROSIS; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MOUSE; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANALYSIS OF VARIANCE; ANIMALS; ATHEROSCLEROSIS; BILIRUBIN; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL LINE; CREB-BINDING PROTEIN; MICE; NF-KAPPA B; PHOSPHORYLATION; PROLINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THIOCARBAMATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951160872     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kelly M, Hwang JM, Kubes P. Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol. 2007; 120:3-10.
2. Young JL, Libby P, Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost. 2002; 88:554-567.
3. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002; 109 (Suppl):S81-S96.
4. Baeuerle PA. Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle? Curr Biol. 1998; 8:R19-R22.
5. May MJ, Ghosh S. Signal transduction through NFkappa B. Immunol Today. 1998; 19:80-88.
6. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 1994; 13:5433-5441.
7. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidantsensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993; 92:1866-1874.
8. Wang AB, Li HL, Zhang R, She ZG, Chen HZ, Huang Y, Liu DP, Liang CC. A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k/Akt singling in vitro and in vivo. J Biomed Sci. 2007; 14:357-371.
9. Edelstein LC, Pan A, Collins T. Chromatin modification and the endothelial-specific activation of the E-selectin gene. J Biol Chem. 2005; 280:11192-11202.
10. Ono H, Ichiki T, Ohtsubo H, Fukuyama K, Imayama I, Iino N, Masuda S, Hashiguchi Y, Takeshita A, Sunagawa K. CAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in endothelial cells. Hypertens Res. 2006; 29:39-47.
11. Neuzil J, Stocker R. Bilirubin attenuates radicalmediated damage to serum albumin. FEBS Lett. 1993; 331:281-284.
12. Rigato I, Ostrow JD, Tiribelli C. Bilirubin and the risk of common non-hepatic diseases. Trends Mol Med. 2005; 11:277-283.
13. Mazzone GL, Rigato I, Ostrow JD, Bossi F, Bortoluzzi A, Sukowati CH, Tedesco F, Tiribelli C. Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules. Biochem Biophys Res Commun. 2009; 386:338-344.
14. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, Novotny L, Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 2002; 160:449-456.
15. Garlanda C, Parravicini C, Sironi M, De Rossi M, Wainstok DC, Carozzi F, Bussolino F, Colotta F, Mantovani A, Vecchi A. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middlesized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proc Natl Acad Sci U S A. 1994; 91:7291-7295.
16. McDonagh AF, Assisi F. The ready isomerization of bilirubin IX- in aqueous solution. Biochem J. 1972; 129:797-800.
17. Roca L, Calligaris S, Wennberg RP, Ahlfors CE, Malik SG, Ostrow JD, Tiribelli C. Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method. Pediatr Res. 2006; 60:724-728.
18. Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, Rots MG, Schouten JP, Limburg PC, Molema G. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol. 2005; 289:C1229-C1239.
19. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29:e45.
20. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11:1475-1489.
21. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol. 2001; 87:1196-1200.
22. Stocker R, Keaney Jr JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004; 84:1381-1478.
23. Jacobsen J, Wennberg RP. Determination of unbound bilirubin in the serum of newborns. Clin Chem. 1974; 20:783.
24. Nelson T, Jacobsen J, Wennberg RP. Effect of pH on the interaction of bilirubin with albumin and tissue culture cells. Pediatr Res. 1974; 8:963-967.
25. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2002; 13:413-421.
26. Lin CW, Chen LJ, Lee PL, Lee CI, Lin JC, Chiu JJ. The inhibition of TNF-alpha-induced E-selectin expression in endothelial cells via the JNK/NF-kappaB pathways by highly N-acetylated chitooligosaccharides. Biomaterials. 2007; 28:1355-1366.
27. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A. 1997; 94:2927-2932.
28. Zerfaoui M, Suzuki Y, Naura AS, Hans CP, Nichols C, Boulares AH. Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction. Cell Signal. 2008; 20:186-194.
29. Fernandes A, Falcao AS, Silva RF, Gordo AC, Gama MJ, Brito MA, Brites D. Inflammatory signalling pathways involved in astroglial activation by unconjugated bilirubin. J Neurochem. 2006; 96:1667-1679.
30. Malek S, Chen Y, Huxford T, Ghosh G. IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NFkappaB nuclear localization sequences in resting cells. J Biol Chem. 2001; 276:45225-45235.
31. Schoonbroodt S, Piette J. Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem Pharmacol. 2000; 60:1075-1083.